Ebola Resource Center

Health officials in Uganda confirmed there is an Ebola virus outbreak in the capital city and that one person has died.

Patients with confirmed Ebola virus disease were around half as likely to die if they were vaccinated against the virus than if they were not, results from a study showed.

Two randomized, placebo-controlled trials of three Ebola vaccine regimens demonstrated that they are safe and spur lasting antibodies in both children and adults, according to findings reported in The New England Journal of Medicine.

The U.S. has begun screening travelers from Uganda in response to the ongoing Ebola outbreak.

Officials have begun assessing Sudan ebolavirus vaccine candidates as case and death counts continue to rise in the ongoing Ebola outbreak in Uganda that has now spread to two more districts in the country.

Health authorities in Uganda on Tuesday declared an Ebola outbreak after a case of Sudan ebolavirus was confirmed.

A study of Ebola survivors showed that 75% have persistent symptoms year after infection, and while these symptoms decline over time, more than half continue to report symptoms up to 5 years after infection.

The Democratic Republic of the Congo has declared a resurgence of Ebola virus after confirming that a case in North Kivu province was linked to a previous outbreak.

WHO has recommended two monoclonal antibody treatments for Ebola virus disease.

The latest Ebola virus outbreak in the Democratic Republic of the Congo has been declared over.